Currently Browsing CPLRG™ by: Case Number
Browse By: Case Date | Case Name

  1. Pages:
  2. 1
  3. ...
  4. 8
  5. 9
  6. 10
  7. 11
  8. 12
  9. 13
  10. 14
  11. 15
  12. 16
  13. 17

CPLRG™ 0053 - Harari v. Hollmer - Apr. 14, 2010

Harari v. Hollmer, 602 F.3d 1348 (Fed. Cir. 2010) (PROST, Bryson & Archer) Harari04192010

MAJOR ISSUES:  applications simultaneously filed; incorporation by reference; continuation application; preliminary amendment adding text of incorporated matter Read CPLRG™ 0053

CPLRG™ 0054 - Gillig v. Nike, Inc. - Apr. 20, 2010

Gillig v. Nike, Inc., 602 F.3d 1354 (Fed. Cir. 2010) (DYK, Linn & Plager)GilligNike04202010

MAJOR ISSUES:  inventorship correction suit; no res judicata effect of dismissal of prior trade secret suit for lack of standing; correction of pending applications Read CPLRG™ 0054

CPLRG™ 0055 - ClearPlay, Inc. v. Abecassis - Apr. 21, 2010

ClearPlay, Inc. v. Abecassis, 602 F.3d 1364, CPLRG 0055 (Fed. Cir. 2010) (BRYSON, Archer & Prost) Clearplay04212010

MAJOR ISSUES: Federal Circuit appellate jurisdiction; case not arising under patent law; state law claims arising from dispute over license agreement in settlement of patent infringement suit; claims provable without necessarily resolving patent law issues Read CPLRG™ 0055

CPLRG™ 0056 - Medtronic Navigation, Inc. v. BrainLAB Medizinische Computersysteme GMBH - Apr. 26, 2010

Medtronic Navigation, Inc. v. BrainLAB Medizinische Computersysteme GMBH, 603 F.3d 943, CPLRG0056 (Fed. Cir. 2010) (BRYSON & Newman; LOURIE, concurring)Medtronic04262010

MAJOR ISSUES:  attorney fee award to prevailing accused infringer;  “exceptional case” determination under 35 U.S.C. § 285; continuing infringement suit after adverse claim construction ruling; theory on doctrine of equivalents and prosecution history estoppel; denial of summary judgment; litigation misconduct; arguments to jury allegedly undermining court’s claim construction Read CPLRG™ 0056

CPLRG™ 0057 - Alza Corp. v. Andrx Pharmaceuticals, LLC - Apr. 27, 2010

Alza Corp. v. Andrx Pharmaceuticals, LLC, 693 F.3d 935, CPLRG 0057 (Fed. Cir. 2010) (PROST, Dyk & Schall) AlzaAndrx04262010

MAJOR ISSUES: enablement; full scope of claim; claim broadly construed to show infringement not enabled; undue experimentation Read CPLRG™ 0057

Currently Browsing CPLRG™ by: Case Number
Browse By: Case Date | Case Name

  1. Pages:
  2. 1
  3. ...
  4. 8
  5. 9
  6. 10
  7. 11
  8. 12
  9. 13
  10. 14
  11. 15
  12. 16
  13. 17

©2010 Donald S. Chisum - All Rights Reserved

Website design by Bluegrass Internet Services